289 related articles for article (PubMed ID: 36090052)
21. Molecular regulatory mechanism of ferroptosis and its role in gastrointestinal oncology: Progress and updates.
Yang F; Sun SY; Wang S; Guo JT; Liu X; Ge N; Wang GX
World J Gastrointest Oncol; 2022 Jan; 14(1):1-18. PubMed ID: 35116100
[TBL] [Abstract][Full Text] [Related]
22. FSP1 is a glutathione-independent ferroptosis suppressor.
Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M
Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899
[TBL] [Abstract][Full Text] [Related]
23. Ferroptosis: A New Strategy for Cancer Therapy.
Chen Y; Fan Z; Hu S; Lu C; Xiang Y; Liao S
Front Oncol; 2022; 12():830561. PubMed ID: 35252001
[TBL] [Abstract][Full Text] [Related]
24. Ferroptosis: a promising candidate for exosome-mediated regulation in different diseases.
Liu L; Ye Y; Lin R; Liu T; Wang S; Feng Z; Wang X; Cao H; Chen X; Miao J; Liu Y; Jiang K; Han Z; Li Z; Cao X
Cell Commun Signal; 2024 Jan; 22(1):6. PubMed ID: 38166927
[TBL] [Abstract][Full Text] [Related]
25. Potential therapies for HCC involving targeting the ferroptosis pathway.
Li D; Zhang M; Liu J; Li Z; Ni B
Am J Cancer Res; 2024; 14(4):1446-1465. PubMed ID: 38726269
[TBL] [Abstract][Full Text] [Related]
26. Study of Ferroptosis Transmission by Small Extracellular Vesicles in Epithelial Ovarian Cancer Cells.
Alarcón-Veleiro C; Mato-Basalo R; Lucio-Gallego S; Vidal-Pampín A; Quindós-Varela M; Al-Qatarneh T; Berrecoso G; Vizoso-Vázquez Á; Arufe MC; Fafián-Labora J
Antioxidants (Basel); 2023 Jan; 12(1):. PubMed ID: 36671044
[TBL] [Abstract][Full Text] [Related]
27. Ferroptosis as a New Type of Cell Death and its Role in Cancer Treatment.
Skoupilová H; Michalová E; Hrstka R
Klin Onkol; 2018; 31(Suppl 2):21-26. PubMed ID: 31023020
[TBL] [Abstract][Full Text] [Related]
28. Posttranslational Modifications in Ferroptosis.
Wei X; Yi X; Zhu XH; Jiang DS
Oxid Med Cell Longev; 2020; 2020():8832043. PubMed ID: 33294126
[TBL] [Abstract][Full Text] [Related]
29. Ferroptosis-Related Gene Signature Promotes Ovarian Cancer by Influencing Immune Infiltration and Invasion.
You Y; Fan Q; Huang J; Wu Y; Lin H; Zhang Q
J Oncol; 2021; 2021():9915312. PubMed ID: 34135962
[TBL] [Abstract][Full Text] [Related]
30. Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer.
Zhang C; Liu N
Front Immunol; 2022; 13():920059. PubMed ID: 35958626
[TBL] [Abstract][Full Text] [Related]
31. Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells.
Battaglia AM; Sacco A; Perrotta ID; Faniello MC; Scalise M; Torella D; Levi S; Costanzo F; Biamonte F
Front Oncol; 2022; 12():868351. PubMed ID: 35433479
[TBL] [Abstract][Full Text] [Related]
32. Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation.
Nakamura T; Mishima E; Yamada N; Mourão ASD; Trümbach D; Doll S; Wanninger J; Lytton E; Sennhenn P; Nishida Xavier da Silva T; Angeli JPF; Sattler M; Proneth B; Conrad M
Nat Struct Mol Biol; 2023 Nov; 30(11):1806-1815. PubMed ID: 37957306
[TBL] [Abstract][Full Text] [Related]
33. Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance.
Liu N; Lin X; Huang C
Br J Cancer; 2020 Jan; 122(2):279-292. PubMed ID: 31819185
[TBL] [Abstract][Full Text] [Related]
34. Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma.
Zhang X; Yu K; Ma L; Qian Z; Tian X; Miao Y; Niu Y; Xu X; Guo S; Yang Y; Wang Z; Xue X; Gu C; Fang W; Sun J; Yu Y; Wang J
Theranostics; 2021; 11(12):5650-5674. PubMed ID: 33897873
[No Abstract] [Full Text] [Related]
35. p53 Promoted Ferroptosis in Ovarian Cancer Cells Treated with Human Serum Incubated-Superparamagnetic Iron Oxides.
Zhang Y; Xia M; Zhou Z; Hu X; Wang J; Zhang M; Li Y; Sun L; Chen F; Yu H
Int J Nanomedicine; 2021; 16():283-296. PubMed ID: 33469287
[TBL] [Abstract][Full Text] [Related]
36. Significance of glutathione peroxidase 4 and intracellular iron level in ovarian cancer cells-"utilization" of ferroptosis mechanism.
Li D; Zhang M; Chao H
Inflamm Res; 2021 Dec; 70(10-12):1177-1189. PubMed ID: 34537856
[TBL] [Abstract][Full Text] [Related]
37. A novel anticancer property of
DU X; Zhang J; Liu L; Xu B; Han H; Dai W; Pei X; Fu X; Hou S
J Zhejiang Univ Sci B; 2022 Apr; 23(4):286-299. PubMed ID: 35403384
[TBL] [Abstract][Full Text] [Related]
38. Research progress on the mechanism of ferroptosis and its clinical application.
Xia J; Si H; Yao W; Li C; Yang G; Tian Y; Hao C
Exp Cell Res; 2021 Dec; 409(2):112932. PubMed ID: 34800540
[TBL] [Abstract][Full Text] [Related]
39. Sodium molybdate inhibits the growth of ovarian cancer cells via inducing both ferroptosis and apoptosis.
Mao G; Xin D; Wang Q; Lai D
Free Radic Biol Med; 2022 Mar; 182():79-92. PubMed ID: 35219846
[TBL] [Abstract][Full Text] [Related]
40. Role of ferroptosis in colorectal cancer.
Song YQ; Yan XD; Wang Y; Wang ZZ; Mao XL; Ye LP; Li SW
World J Gastrointest Oncol; 2023 Feb; 15(2):225-239. PubMed ID: 36908317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]